CorriXR Therapeutics Names Eric Kmiec, Ph.D., as Chief Executive Officer

CorriXR Therapeutics, Inc., a leading biotherapeutics company focused on oncology and innovative technologies to overcome drug resistance in solid tumors, has announced that Eric Kmiec, Ph.D., the company’s founder and chief scientific officer, will assume the role of chief executive officer. “We are confident that Eric’s exceptional leadership will drive CorriXR forward in its mission […]

The post CorriXR Therapeutics Names Eric Kmiec, Ph.D., as Chief Executive Officer appeared first on ChristianaCare News.